May 2014—Biocare Medical released a mouse monoclonal SOX10 antibody. SOX10 is expressed in 97 to 100 percent of desmoplastic and spindle cell melanomas and in 100 percent of nevi. The majority of oligodendrogliomas, but also a large percentage of astrocytomas and poorly differentiated glioblastomas, have also been shown to express SOX10.
Biocare Medical, 800-799-9499